92 related articles for article (PubMed ID: 3941331)
1. Sequential therapy with methotrexate and 5-fluorouracil in the treatment of advanced colorectal carcinoma.
Leone BA; Romero A; Rabinovich MG; Perez JE; Macchiavelli M; Strauss E
J Clin Oncol; 1986 Jan; 4(1):23-7. PubMed ID: 3941331
[TBL] [Abstract][Full Text] [Related]
2. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
Petrelli N; Herrera L; Rustum Y; Burke P; Creaven P; Stulc J; Emrich LJ; Mittelman A
J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW
J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
[TBL] [Abstract][Full Text] [Related]
5. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
[TBL] [Abstract][Full Text] [Related]
6. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
[TBL] [Abstract][Full Text] [Related]
7. Sequential methotrexate--5-FU--leucovorin (MFL) in advanced colorectal cancer.
Glimelius B; Ginman C; Graffman S; Påhlman L; Ståhle E
Eur J Cancer Clin Oncol; 1986 Mar; 22(3):295-300. PubMed ID: 3486768
[TBL] [Abstract][Full Text] [Related]
8. [Sequential therapy with methotrexate and 5-fluorouracil in patients with advanced colorectal cancer pretreated with 5-fluorouracil plus folinic acid].
Paoletti G; Di Lauro L; Gionfra T; Venturo I; Belli F; Squilloni E; Mariotti S; Fioretti G; Gemini M; Tersigni R; Lopez M
Clin Ter; 1998; 149(2):105-8. PubMed ID: 9780473
[TBL] [Abstract][Full Text] [Related]
9. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
[TBL] [Abstract][Full Text] [Related]
10. Double-modulation of 5-Fluorouracil by methotrexate and leucovorin in advanced colorectal-carcinoma.
Leone B; Romero A; Rabinovich M; Vallejo C; Bianco A; Perez J; Rodriguez R; Cuevas M; Machiavelli M; Paris A; Lacava J
Int J Oncol; 1993 Nov; 3(5):995-9. PubMed ID: 21573464
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer.
Panasci L; Ford J; Margolese R
Cancer Chemother Pharmacol; 1985; 15(2):164-6. PubMed ID: 4017165
[TBL] [Abstract][Full Text] [Related]
12. Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.
Hejna M; Kornek GV; Raderer M; Depisch D; Brodowicz T; Fiebiger WC; Scheithauer W
Br J Cancer; 1998 Sep; 78(6):760-4. PubMed ID: 9743296
[TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study.
Hines JD; Zakem MH; Adelstein DJ; Rustum YM
J Clin Oncol; 1988 Jan; 6(1):142-6. PubMed ID: 3257256
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
15. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G
Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846
[TBL] [Abstract][Full Text] [Related]
16. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer.
Blanke CD; Kasimis B; Schein P; Capizzi R; Kurman M
J Clin Oncol; 1997 Mar; 15(3):915-20. PubMed ID: 9060528
[TBL] [Abstract][Full Text] [Related]
19. Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.
Nordic Gastrointestinal Tumor Adjuvant Therapy Group
J Clin Oncol; 1989 Oct; 7(10):1437-46. PubMed ID: 2674332
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]